BackSteminent Biotherapeutics Overview

Steminent Biotherapeutics Current Cash

Track Steminent Biotherapeutics's current cash ($820M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$824.61M

Peer trimmed avg / median

Loading

Steminent Biotherapeutics Current Cash History

Loading

Steminent Biotherapeutics vs. peers: Current Cash Comparison

Loading

Steminent Biotherapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Steminent Biotherapeutics (7729.TWO) FAQ

As of the most recent data (September 2026), 7729.TWO shows a current cash of $820M. Scroll down for historical charts and peer comparison views.

Tracking 7729.TWO's current cash over time shows whether Steminent Biotherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $820M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Steminent Biotherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $820M) with ownership activity and broader fundamentals.

Steminent Biotherapeutics's current cash is $820M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.